Point72 Middle East Fze Mersana Therapeutics, Inc. Transaction History

Point72 Middle East Fze

  • $0
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$1.11 - $2.34 $1,295 - $2,730
1,167 Added 4.79%
25,511 $59,000
Q3 2023

Nov 14, 2023
BUY
$1.06 - $3.91 $25,804 - $95,185
24,344 New
24,344 $30,000
Q1 2023

May 15, 2023
BUY
$4.0 - $7.02 $25,640 - $44,998
6,410 Added 67.01%
15,976 $65,000
Q4 2022

Feb 14, 2023
BUY
$5.65 - $7.86 $54,047 - $75,188
9,566 New
9,566 $0

Others Institutions Holding MRSN

# of Institutions
125
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $52.5M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email